Arguably it has failed, but don't tell my fundamental side of my brain which remains bullishly biased on the story and "softer side" of biotech investing paying attention to specifically the anecdotal clues within the Rett Syndrome indication.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.